equitysell

IGF

Trust-weighted public proof page for IGF. See which authors support it, which ticker theses it belongs to, and how thesis calls have performed.

Opportunity

69 / 100

Current score

-1.23

Thesis calls

Active decisions

Recent proof-backed thesis calls

Public preview of asset-level thesis calls linked to source content, observed prices, and outcomes.

aestheticprimalxopen

Content discusses human endocrinology (GH/LH/IGF-1, insulin, Leydig cell sensitivity, HPG axis) and makes no explicit market, company, sector, macro, or investable-asset claims. Not directly translatable into a tradable catalyst without additional context (e.g., drug/company linkage, clinical results, regulation, product demand).

Mentioned: Jul 24, 2026, 10:32 AM EDTConviction: 60 / 100

View source

Source: _aestheticprimal_ @aestheticprimal 29m GH follows the same pattern as LH, in the way it rises in effort of overcompen...